相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database
Patrick Blin et al.
ATHEROSCLEROSIS (2019)
One-year clinical outcomes of ticagrelor compared with clopidogrel after percutaneous coronary intervention in patients with acute myocardial infarction: From Korean Health Insurance Review and Assessment Data
Choongki Kim et al.
JOURNAL OF CARDIOLOGY (2019)
Safety and Effectiveness of Contemporary P2Y12 Inhibitors in an East Asian Population With Acute Coronary Syndrome: A Nationwide Population-Based Cohort Study
Ji Eun Yun et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management A Randomized Clinical Trial
Duk-Woo Park et al.
CIRCULATION (2019)
Clinical Outcomes of Plavix and Generic Clopidogrel for Patients Hospitalized With an Acute Coronary Syndrome
Dennis T. Ko et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Clinical Outcomes of Plavix and Generic Clopidogrel for Patients Hospitalized With an Acute Coronary Syndrome
Dennis T. Ko et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and Asian Paradox
Jeehoon Kang et al.
KOREAN CIRCULATION JOURNAL (2018)
Clopidogrel, prasugrel, or ticagrelor use and clinical outcome in patients with acute coronary syndrome: A nationwide long-term registry analysis from 2009 to 2014
Safoura Sheikh Rezaei et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data
Jee-Ae Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
Head to head comparison of Prasugrel versus Ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials
Pravesh Kumar Bundhun et al.
BMC PHARMACOLOGY & TOXICOLOGY (2017)
Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention
M. B. Yudi et al.
INTERNAL MEDICINE JOURNAL (2016)
Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry-National Institute of Health
Keun-Ho Park et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Contemporary Use of Ticagrelor in Interventional Practice (from Blue Cross Blue Shield of Michigan Cardiovascular Consortium)
Amrita M. Karve et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Ticagrelor vs. Clopidogrel in Japanese, Korean and Taiwanese Patients With Acute Coronary Syndrome - Randomized, Double-Blind, Phase III PHILO Study -
Shinya Goto et al.
CIRCULATION JOURNAL (2015)
Prasugrel hydrochloride for the treatment of acute coronary syndromes
Thibault Lhermusier et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
How to manage prasugrel and ticagrelor in daily practice
Fanny Bonhomme et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)
World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
Glenn N. Levine et al.
NATURE REVIEWS CARDIOLOGY (2014)
East Asian Paradox: Challenge for the Current Antiplatelet Strategy of One-Guideline-Fits-All Races in Acute Coronary Syndrome
Young-Hoon Jeong
CURRENT CARDIOLOGY REPORTS (2014)
Claims-Based Definition of Death in Japanese Claims Database: Validity and Implications
Nobuhiro Ooba et al.
PLOS ONE (2013)
Clopidogrel, Prasugrel, or Ticagrelor? A Practical Guide to Use of Antiplatelet Agents in Patients With Acute Coronary Syndromes
Nicholas B. Norgard et al.
POSTGRADUATE MEDICINE (2013)
Ticagrelor: a P2Y12 antagonist for use in acute coronary syndromes
Yanushi Dullewe Wijeyeratne et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
Validity of the Diagnosis of Acute Myocardial Infarction in Korean National Medical Health Insurance Claims Data: The Korean Heart Study (1)
Heejin Kimm et al.
KOREAN CIRCULATION JOURNAL (2012)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
Richard C. Becker et al.
EUROPEAN HEART JOURNAL (2011)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prevention of premature ditscontinuation of dual antiplatelet therapy in patients with coronary artery stents
Cindy L. Grines et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
分享论文
